TCM
TMO icon

Twin Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Twin Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306K Hold
622
– – 0.04% 264
2025
Q4 		$360K Sell
622
-54
-8% -$30.5K 0.04% 242
2025
Q3 		$328K Hold
676
– – 0.04% 252
2025
Q2 		$274K Sell
676
-35
-5% -$14.6K 0.03% 249
2025
Q1 		$354K Sell
711
-17
-2% -$9.21K 0.04% 259
2024
Q4 		$379K Sell
728
-15
-2% -$8.25K 0.04% 262
2024
Q3 		$460K Sell
743
-33
-4% -$19.5K 0.05% 248
2024
Q2 		$429K Buy
+776
New +$445K 0.05% 238
2023
Q3 		– Sell
-6,719
Closed -$3.51M – 293
2023
Q2 		$3.51M Sell
6,719
-742
-10% -$400K 0.46% 52
2023
Q1 		$4.3M Sell
7,461
-1,454
-16% -$820K 0.59% 34
2022
Q4 		$4.91M Sell
8,915
-308
-3% -$163K 0.64% 33
2022
Q3 		$4.68M Sell
9,223
-195
-2% -$109K 0.63% 32
2022
Q2 		$5.12M Sell
9,418
-1,786
-16% -$983K 0.65% 32
2022
Q1 		$6.62M Sell
11,204
-20
-0.2% -$11.5K 0.71% 25
2021
Q4 		$7.49M Sell
11,224
-1,120
-9% -$699K 0.75% 26
2021
Q3 		$7.05M Sell
12,344
-1,640
-12% -$900K 0.72% 25
2021
Q2 		$7.05M Buy
13,984
+237
+2% +$112K 0.65% 33
2021
Q1 		$6.27M Sell
13,747
-1,355
-9% -$647K 0.62% 37
2020
Q4 		$7.03M Buy
+15,102
New +$7.08M 0.64% 37
2017
Q4 		– Sell
-27,200
Closed -$5.15M – 351
2017
Q3 		$5.15M Sell
27,200
-150
-0.5% -$27.2K 0.27% 116
2017
Q2 		$4.77M Sell
27,350
-140
-0.5% -$23.5K 0.28% 112
2017
Q1 		$4.22M Sell
27,490
-3,960
-13% -$605K 0.26% 120
2016
Q4 		$4.44M Buy
31,450
+11,280
+56% +$1.66M 0.29% 107
2016
Q3 		$3.21M Sell
20,170
-300
-1% -$46.2K 0.21% 145
2016
Q2 		$3.02M Buy
+20,470
New +$3.02M 0.23% 133
2014
Q2 		– Sell
-5,230
Closed -$629K – 313
2014
Q1 		$629K Buy
+5,230
New +$622K 0.07% 263

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Twin Capital Management's TMO Position: Q1 2026 in Review

Twin Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 622 shares worth $306K. The position accounts for 0.04% of the portfolio, ranked #264.

Twin Capital Management first reported a position in TMO in Q1 2014 and has held it in 26 quarters since. The position peaked at $7.49M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Twin Capital Management held 622 shares of Thermo Fisher Scientific worth $306K as of Q1 2026.
  • Twin Capital Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
  • Thermo Fisher Scientific made up 0.04% of Twin Capital Management's portfolio in Q1 2026, its #264 holding.
  • Twin Capital Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 26 quarters since.
  • Twin Capital Management's Thermo Fisher Scientific position peaked at $7.49M in Q4 2021.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.